FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease.
Newly Approved Pancreatic Cancer Treatment Has Been Shown To Prolong Life — And Highlights Siteman’s Role in Bringing Innovation to Patients (Links to an external site)
















